ASCO frequently highlights the work of State Affiliates in The ASCO Post. The most recent state society to be featured is the Washington State Medical Oncology Society. Here is an excerpt from the June 25, 2014 article in The ASCO Post:
"The Washington State Medical Oncology Society (WSMOS) was formed in 1993 in response to the health-care reform legislation then being proposed by President Bill Clinton. “The law never passed, but it spurred the development of our Society, so some good came out of the law’s defeat,” said Vicky E. Jones, MD, President of WSMOS."
Read the full article featuring the Washington State Medical Oncology Society.
Previous issues of The ASCO Post featuring ASCO Affiliates:
- Connecting to ASCO Through the State Affiliate Council (4/15/14)
- Virginia Association of Hematologists and Oncologists (3/15/14)
- Michigan Society of Hematology and Oncology (2/15/14)
- Massachusetts Society of Clinical Oncologists (12/15/13)
- Texas Society of Clinical Oncology (11/15/13)
- Wisconsin Association of Hematology and Oncology (10/15/13)
- West Virginia Oncology Society (8/15/13)
- Society of Rhode Island Clinical Oncologists (7/10/13)
- Georgia Society of Clinical Oncology (6/25/13)
- Delaware Society for Clinical Oncology (6/10/13)
- Denali Oncology Group (5/15/13)
- Louisiana Oncology Society (4/15/13)
- Medical Oncology Association of Southern California (3/15/13)
If your society is interested in being featured in The ASCO Post, please contact Melissa.Reifler@asco.org.
In the past, the ASCO State/Regional Affiliate Program partnered with ASCO Connection to present a bimonthly, online column titled "Spotlight on State Affiliates" to increase awareness of the important work being pursued by ASCO State/Regional Affiliates.
The Michigan Society of Hematology and Oncology was the last Affiliate to be featured.
"The Michigan Society of Hematology and Oncology (MSHO) was formed in 1985 in response to unfavorable changes in Medicare reimbursement and consistent coverage issues with Michigan's private payers that jeopardized the specialists' ability to deliver quality care. Twenty seven years later, the need to advocate for the advancement of cancer treatment as a recognized, credible, unified, local "Voice of Oncology" remains."